Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Inozyme Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −7 vs. Q4 2024
- Shares held
- 46.7M
- −5.42M (−10.4%) vs. Q4 2024
- Total value
- $42.5M
- −$101.9M (−70.6%) vs. Q4 2024
- New holders
- 13
- 30 more added
- Sold out
- 20
- 28 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 87 | $202.3M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 105 | $145.1M |
| Q3 2024 | 89 | $285.5M |
| Q2 2024 | 90 | $240.1M |
| Q1 2024 | 89 | $382.0M |
| Q4 2023 | 80 | $213.3M |
| Q3 2023 | 77 | $204.6M |
| Q2 2023 | 74 | $190.3M |
| Q1 2023 | 50 | $183.4M |
| Q4 2022 | 37 | $30.4M |
| Q3 2022 | 39 | $82.7M |
| Q2 2022 | 47 | $149.4M |
| Q1 2022 | 50 | $71.2M |
| Q4 2021 | 51 | $118.2M |
| Q3 2021 | 52 | $202.7M |
| Q2 2021 | 50 | $337.1M |
| Q1 2021 | 55 | $379.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | $0 | 0.00% | −89,291−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −83,919−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −79,349−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −63,799−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −62,886−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −53,588−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −39,115−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −23,958−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −20,745−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −17,375−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −12,044−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −11,155−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −6,550−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −3,478−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −730−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −425−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −314−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |